Alterations in parenteral nutrition management for the treatment of parenteral nutrition-associated cholestasis in term and preterm infants

To assess the benefits and risks of alterations in PN components or PN administration for parenteral nutrition-associated cholestasis in term and preterm infants. Such alterations will include but not be limited to addition or elimination of specific PN components, increases or decreases in concentration of specific PN components, or changes in method of PN administration.

This is a protocol.

Share/Save